07.05.2014 • Topics

Cooperation Creates Broad Portfolio at Best Market Price

Dr. Bernd Soyke, CEO, Penta
Dr. Bernd Soyke, CEO, Penta

What kind of growth do you aspire to in the next few years?

We expect organic growth through expansion of our customer and product portfolio as well as offering new services to our customers.

In which sectors, markets or regions do you see significant growth opportunities?

Generally, we see opportunities in all sectors where we are active. As a cooperation network with focus on the European chemical distribution segment, we have growth opportunities in many different regions, markets and sectors.

How do you intend to implement these plans and seize these opportunities?

Penta takes its chances out of the cooperation. Our shareholding companies as well as our cooperation partners form a strong alliance in order to offer our customers a broad product and service portfolio in virtually every place in Europe at the best market price possible. This has been our success factor for almost 50 years.

 

Company

Penta Chemikalien GmbH & Co.KG


Mainaschaff
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read